We found that samples representing those two clusters did not differ with any of the following features: tumor stage, tumor grade, response to chemotherapy, residual tumor size, germline breast cancer (BRCA)1 mutation, somatic p53 mutation, or p53 protein accumulation. This evidence concerns the gene TP53 and neoplasm.